UA99278C2 - Способ получения существенно очищенных капсульных полисахаридов из лизата клеток streptococcus pneumoniae - Google Patents

Способ получения существенно очищенных капсульных полисахаридов из лизата клеток streptococcus pneumoniae

Info

Publication number: UA99278C2
Authority: UA; Ukraine
Prior art keywords: streptococcus pneumoniae; production; purification process; less; precipitated
Prior art date: 2007-03-23

Application number

UAA200909741A

Other languages

English (en)

Ukrainian (uk)

Inventor

Йонгхуи Юан

Марк Руппен

Вэй-Цианг Сан

Линг ЧУ

Джон СИМПСОН

Джэймс Пэтч

Шарбонно Памэла Финк

Джастин К. Моран

Original Assignee

УАЙЕТ ЭлЭлСи

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-03-23

Filing date

2008-03-20

Publication date

2012-08-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39712482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA99278(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-03-20 Application filed by УАЙЕТ ЭлЭлСи filed Critical УАЙЕТ ЭлЭлСи

2012-08-10 Publication of UA99278C2 publication Critical patent/UA99278C2/ru

Links

150000004676 glycans Chemical class 0.000 title abstract 4
229920001282 polysaccharide Polymers 0.000 title abstract 4
239000005017 polysaccharide Substances 0.000 title abstract 4
241000193998 Streptococcus pneumoniae Species 0.000 title abstract 2
229940031000 streptococcus pneumoniae Drugs 0.000 title abstract 2
238000004519 manufacturing process Methods 0.000 title 1
238000000746 purification Methods 0.000 title 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 2
239000003795 chemical substances by application Substances 0.000 abstract 2
239000006166 lysate Substances 0.000 abstract 2
230000002101 lytic effect Effects 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
102000004169 proteins and genes Human genes 0.000 abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 2
FHHPUSMSKHSNKW-SMOYURAASA-M sodium deoxycholate Chemical compound [Na+].C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 FHHPUSMSKHSNKW-SMOYURAASA-M 0.000 abstract 2
ADWNFGORSPBALY-UHFFFAOYSA-M sodium;2-[dodecyl(methyl)amino]acetate Chemical compound [Na+].CCCCCCCCCCCCN(C)CC([O-])=O ADWNFGORSPBALY-UHFFFAOYSA-M 0.000 abstract 2
241000194017 Streptococcus Species 0.000 abstract 1
230000001413 cellular effect Effects 0.000 abstract 1
238000011026 diafiltration Methods 0.000 abstract 1
238000001914 filtration Methods 0.000 abstract 1
238000010979 pH adjustment Methods 0.000 abstract 1
230000020477 pH reduction Effects 0.000 abstract 1
238000013060 ultrafiltration and diafiltration Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
- C07H1/08—Separation; Purification from natural products
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Epidemiology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Materials Engineering (AREA)
Polymers & Plastics (AREA)
Mycology (AREA)
General Engineering & Computer Science (AREA)
Sustainable Development (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

UAA200909741A 2007-03-23 2008-03-20 Способ получения существенно очищенных капсульных полисахаридов из лизата клеток streptococcus pneumoniae UA99278C2 (ru)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US89661607P	2007-03-23	2007-03-23

Publications (1)

Publication Number	Publication Date
UA99278C2 true UA99278C2 (ru)	2012-08-10

Family

ID=39712482

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UAA200909741A UA99278C2 (ru)	2007-03-23	2008-03-20	Способ получения существенно очищенных капсульных полисахаридов из лизата клеток streptococcus pneumoniae

Country Status (29)

Country	Link
US (3)	US8652480B2 (ru)
EP (3)	EP3406635B1 (ru)
JP (5)	JP5688902B2 (ru)
KR (2)	KR101500771B1 (ru)
CN (1)	CN101663327B (ru)
AU (1)	AU2008231041B2 (ru)
BR (1)	BRPI0809212B8 (ru)
CA (1)	CA2681570C (ru)
CL (2)	CL2008000831A1 (ru)
CO (1)	CO6251324A2 (ru)
CR (1)	CR11041A (ru)
DK (3)	DK2129693T3 (ru)
EC (1)	ECSP099652A (ru)
ES (3)	ES2922132T3 (ru)
GT (1)	GT200900249A (ru)
HN (1)	HN2009001965A (ru)
HU (3)	HUE039169T2 (ru)
IL (1)	IL201106A (ru)
MX (1)	MX2009010221A (ru)
MY (1)	MY150927A (ru)
NI (1)	NI200900172A (ru)
NZ (1)	NZ580134A (ru)
PL (3)	PL2129693T3 (ru)
PT (3)	PT2129693T (ru)
RU (1)	RU2516340C2 (ru)
SI (3)	SI2129693T1 (ru)
UA (1)	UA99278C2 (ru)
WO (1)	WO2008118752A2 (ru)
ZA (1)	ZA200906625B (ru)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK2129693T3 (en) *	2007-03-23	2017-02-13	Wyeth Llc	BRIEF PURIFICATION PROCEDURE FOR THE PREPARATION OF STREPTOCOCCUS PNEUMONIAE-Capsule POLYACCHARIDES
GB0818453D0 (en) *	2008-10-08	2008-11-12	Novartis Ag	Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
CN102264444B (zh)	2008-10-27	2015-08-05	诺华股份有限公司	纯化方法
DK2379734T3 (en) *	2008-12-18	2018-04-23	Wyeth Llc	Method for Controlling the Molecular Weight of Polysaccharide of Streptococcus Pneumoniae Serotype 19A
ES2749952T3 (es) *	2008-12-18	2020-03-24	Wyeth Llc	Procedimiento de control del peso molecular de polisacáridos de Streptococcus pneumoniae usando carbono
WO2010125480A1 (en)	2009-04-30	2010-11-04	Coley Pharmaceutical Group, Inc.	Pneumococcal vaccine and uses thereof
CN102481352A (zh)	2009-06-22	2012-05-30	惠氏有限责任公司	金黄色葡萄球菌抗原的免疫原性组合物
SA114350400B1 (ar)	2009-06-22	2016-05-26	ويث ال ال سي	تركيبات وطرق لتحضير تركيبات مولدة للمناعة لمقترن بولي سكاريد كبسولي للنمط المصلي 5 و 8 من المكورات العنقودية الذهبية
TW201136603A (en) *	2010-02-09	2011-11-01	Merck Sharp & Amp Dohme Corp	15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
US8841104B2 (en)	2010-04-21	2014-09-23	Nanomr, Inc.	Methods for isolating a target analyte from a heterogeneous sample
US20110262989A1 (en)	2010-04-21	2011-10-27	Nanomr, Inc.	Isolating a target analyte from a body fluid
US9476812B2 (en)	2010-04-21	2016-10-25	Dna Electronics, Inc.	Methods for isolating a target analyte from a heterogeneous sample
WO2011145108A2 (en) *	2010-05-15	2011-11-24	Serum Institute Of India Ltd.	Purification of capsular polysaccharides
JP5944480B2 (ja) *	2011-03-22	2016-07-05	セルム・インスティテュート・オブ・インディア・ピーブイティー．・リミテッド	多糖を調製するための新規な方法
CN102660601B (zh) *	2012-04-17	2015-10-28	江苏康泰生物医学技术有限公司	快速纯化细菌荚膜多糖的方法
CN102660603B (zh) *	2012-04-17	2015-03-25	江苏康泰生物医学技术有限公司	一种快速纯化细菌荚膜多糖的方法
CN102660602B (zh) *	2012-04-17	2015-03-25	江苏康泰生物医学技术有限公司	快速纯化细菌荚膜多糖的方法
US9650411B2 (en) *	2012-08-07	2017-05-16	Kyowa Hakko Kirin Co., Ltd.	Method of purifying protein
MX363051B (es)	2012-09-07	2019-03-06	Sk Bioscience Co Ltd	Metodo para producir un polisacárido capsular con un serotipo de neumococo.
AR092896A1 (es)	2012-10-03	2015-05-06	Novartis Ag	Composiciones inmunogenicas
US9804069B2 (en)	2012-12-19	2017-10-31	Dnae Group Holdings Limited	Methods for degrading nucleic acid
US10000557B2 (en)	2012-12-19	2018-06-19	Dnae Group Holdings Limited	Methods for raising antibodies
US9599610B2 (en)	2012-12-19	2017-03-21	Dnae Group Holdings Limited	Target capture system
US9434940B2 (en)	2012-12-19	2016-09-06	Dna Electronics, Inc.	Methods for universal target capture
US9551704B2 (en)	2012-12-19	2017-01-24	Dna Electronics, Inc.	Target detection
US9995742B2 (en)	2012-12-19	2018-06-12	Dnae Group Holdings Limited	Sample entry
WO2015005961A1 (en)	2013-07-12	2015-01-15	Emd Millipore Corporation	A method of determining virus removal from a sample containing a target protein using activated carbon
WO2015095868A1 (en)	2013-12-20	2015-06-25	Wake Forest University Health Sciences	Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
PT3096785T (pt)	2014-01-21	2020-10-13	Pfizer	Composições imunogénicas que compreendem antigénios de sacáridos capsulares conjugados e utilizações das mesmas
US11160855B2 (en)	2014-01-21	2021-11-02	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
SI3096783T1 (sl)	2014-01-21	2021-09-30	Pfizer Inc.	Kapsularni polisaharidi streptococcus pneumoniae in njihovi konjugati
KR20210032013A (ko)	2014-01-21	2021-03-23	화이자 인코포레이티드	스트렙토코쿠스 뉴모니아에 피막 폴리사카라이드 및 그의 접합체
US9815886B2 (en)	2014-10-28	2017-11-14	Adma Biologics, Inc.	Compositions and methods for the treatment of immunodeficiency
EP3244917B1 (en)	2015-01-15	2023-04-19	Pfizer Inc.	Immunogenic compositions for use in pneumococcal vaccines
TWI807252B (zh)	2015-05-04	2023-07-01	美商輝瑞股份有限公司	Ｂ型鏈球菌多醣-蛋白質軛合物、製造軛合物之方法、含軛合物之免疫原性組成物、及其用途
WO2016204265A1 (ja) *	2015-06-18	2016-12-22	一般財団法人阪大微生物病研究会	肺炎球菌補体依存性殺菌能測定方法
KR102225282B1 (ko)	2015-07-21	2021-03-10	화이자 인코포레이티드	접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
CN105131139B (zh) *	2015-07-31	2018-02-13	兰州生物制品研究所有限责任公司	一种肺炎链球菌荚膜多糖的纯化方法
CA3005524C (en)	2015-11-20	2023-10-10	Pfizer Inc.	Immunogenic compositions for use in pneumococcal vaccines
TWI770044B (zh)	2016-08-05	2022-07-11	南韓商Ｓｋ生物科技股份有限公司	多價肺炎球菌多醣-蛋白質共軛物組成物(一)
SG11201900794PA (en)	2016-08-05	2019-02-27	Sanofi Pasteur Inc	Multivalent pneumococcal polysaccharide-protein conjugate composition
US10751402B2 (en)	2016-11-09	2020-08-25	Pfizer Inc.	Immunogenic compositions and uses thereof
US11951165B2 (en)	2016-12-30	2024-04-09	Vaxcyte, Inc.	Conjugated vaccine carrier proteins
MX2019007910A (es)	2016-12-30	2019-12-05	Sutrovax Inc	Conjugados de polipeptido-antigeno con aminoacidos no naturales.
MX392525B (es)	2017-01-20	2025-03-12	Pfizer	Composiciones inmunogenicas para su uso en vacunas neumococicas
KR20240169144A (ko)	2017-01-31	2024-12-02	머크 샤프 앤드 돔 엘엘씨	다당류-단백질 접합체 제조 방법
US20200222550A1 (en)	2017-01-31	2020-07-16	Merck Sharp & Dohme Corp.	Methods for production of capsular polysaccharide protein conjugates from streptococcus pneumoniae serotype 19f
KR102701633B1 (ko)	2017-02-24	2024-09-02	머크 샤프 앤드 돔 엘엘씨	폐렴구균 접합체 백신 제제
KR20190121330A (ko)	2017-02-24	2019-10-25	머크 샤프 앤드 돔 코포레이션	스트렙토코쿠스 뉴모니아에 폴리사카라이드-단백질 접합체의 면역원성의 증진
US10259865B2 (en)	2017-03-15	2019-04-16	Adma Biologics, Inc.	Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
KR20240018698A (ko)	2017-06-10	2024-02-13	인벤트프라이즈 인크.	면역원성과 항원항체 결합성이 개선된 2가 또는 다가 접합체 다당류를 가진 다가 접합체 백신
US10729763B2 (en)	2017-06-10	2020-08-04	Inventprise, Llc	Mixtures of polysaccharide-protein pegylated compounds
US10435433B2 (en)	2017-07-05	2019-10-08	Inventprise, Llc	Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
US10702596B2 (en)	2017-07-05	2020-07-07	Inventprise, Llc	Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
WO2019050813A1 (en)	2017-09-07	2019-03-14	Merck Sharp & Dohme Corp.	ANTI-PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN IMMUNOGENIC CONJUGATES POLYSACCHARIDE-PROTEIN CARRIER
BR112020004509A8 (pt)	2017-09-07	2023-01-31	Merck Sharp & Dohme	Conjugado polissacarídeo-proteína carreadora, composição imunogênica compreendendo o mesmo e uso do referido conjugado
US11389540B2 (en)	2017-09-07	2022-07-19	Merck Sharp & Dohme Llc	Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
CN107936128B (zh) *	2017-11-22	2020-07-03	成都欧林生物科技股份有限公司	一种简便有效的细菌疫苗纯化方法
BR112020011414B8 (pt)	2017-12-06	2023-01-31	Merck Sharp & Dohme	Composições imunogênicas multivalentes compreendendo conjugados de proteína carreadora e polissacarídeo de s. pneumoniae
BR112020014978A2 (pt)	2018-02-05	2020-12-22	Sanofi Pasteur, Inc.	Composição de conjugado polissacarídeo-proteína pneumocócico multivalente
KR20230008923A (ko)	2018-02-05	2023-01-16	사노피 파스퇴르 인코포레이티드	다가 폐렴구균성 다당류-단백질 접합체 조성물
US12144855B2 (en)	2018-04-30	2024-11-19	Merck Sharp & Dohme Llc	Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
JP7397000B2 (ja)	2018-04-30	2023-12-12	メルク・シャープ・アンド・ドーム・エルエルシー	凍結乾燥変異ジフテリア毒素のジメチルスルホキシド中均一溶液を提供する方法
US20210252125A1 (en)	2018-04-30	2021-08-19	Merck Sharp & Dohme Corp.	Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates
DK3817775T3 (da)	2018-07-04	2024-09-16	Vaxcyte Inc	Forbedringer i immunogene konjugater
WO2020010016A1 (en)	2018-07-04	2020-01-09	Sutrovax, Inc.	Self-adjuvanted immunogenic conjugates
WO2020010000A1 (en)	2018-07-04	2020-01-09	Sutrovax, Inc.	Improved methods for the preparation of immunogenic conjugates
US12018134B2 (en) *	2018-07-19	2024-06-25	Glaxosmithkline Biological Sa	Processes for preparing dried polysaccharides
JP7585203B2 (ja)	2018-12-12	2024-11-18	ファイザー・インク	免疫原性多重ヘテロ抗原多糖－タンパク質コンジュゲートおよびその使用
EP3897705A2 (en)	2018-12-19	2021-10-27	Merck Sharp & Dohme Corp.	Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof
JP7239509B6 (ja) *	2019-02-22	2023-03-28	ファイザー・インク	細菌多糖類を精製するための方法
CA3136278A1 (en)	2019-04-10	2020-10-15	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
PH12022550110A1 (en)	2019-07-31	2022-12-12	Sk Bioscience Co Ltd	Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
US12473379B2 (en) *	2019-09-06	2025-11-18	Serum Institute Of India Private Limited	Method for obtaining purified bacterial polysaccharides
MX2022010355A (es)	2020-02-21	2022-09-21	Pfizer	Purificacion de sacaridos.
KR20230022867A (ko) *	2020-06-12	2023-02-16	바스프 에스이	발효 브로스의 개선된 탈염 및 올리고당과 같은 정밀 화학물질의 정제
EP4192499A4 (en)	2020-08-10	2024-09-25	Inventprise, Inc.	Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f
CA3192786A1 (en)	2020-08-26	2022-03-03	Pfizer Inc.	Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
GB202016165D0 (en)	2020-10-12	2020-11-25	Optivalent Ltd	Vaccine
EP4232593A1 (en)	2020-10-22	2023-08-30	Pfizer Inc.	Methods for purifying bacterial polysaccharides
CA3200602A1 (en)	2020-11-04	2022-05-12	Pfizer Inc.	Immunogenic compositions for use in pneumococcal vaccines
US20230405137A1 (en)	2020-11-10	2023-12-21	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
TW202245835A (zh)	2021-02-04	2022-12-01	美商默沙東有限責任公司	用於肺炎球菌結合物疫苗之奈米乳化液佐劑組合物
WO2022234416A1 (en)	2021-05-03	2022-11-10	Pfizer Inc.	Vaccination against pneumoccocal and covid-19 infections
WO2022234405A1 (en)	2021-05-03	2022-11-10	Pfizer Inc.	Vaccination against bacterial and betacoronavirus infections
KR20230175284A (ko)	2021-05-28	2023-12-29	화이자 인코포레이티드	접합된 피막 사카라이드 항원을 포함하는 면역원성 조성물 및 그의 용도
CA3221075A1 (en)	2021-05-28	2022-12-01	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2023135515A1 (en)	2022-01-13	2023-07-20	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
GB2614916A (en)	2022-01-25	2023-07-26	Optivalent Ltd	Intradermal vaccine complement
US20250163484A1 (en)	2022-02-25	2025-05-22	Pfizer Inc.	Methods for Incorporating Azido Groups in Bacterial Capsular Polysaccharides
WO2024084397A1 (en)	2022-10-19	2024-04-25	Pfizer Inc.	Vaccination against pneumoccocal and covid-19 infections
WO2024110827A1 (en)	2022-11-21	2024-05-30	Pfizer Inc.	Methods for preparing conjugated capsular saccharide antigens and uses thereof
IL321062A (en)	2022-11-22	2025-07-01	Pfizer	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
KR20250113501A (ko)	2022-12-01	2025-07-25	화이자 인코포레이티드	폐렴구균 접합체 백신 제형
WO2024166008A1 (en)	2023-02-10	2024-08-15	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CN121038808A (zh)	2023-03-30	2025-11-28	辉瑞公司	包含缀合的荚膜糖抗原的免疫原性组合物及其用途
PE20252779A1 (es)	2023-04-14	2025-12-22	Pfizer	Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados y usos de estos
WO2024224266A1 (en)	2023-04-24	2024-10-31	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
GEAP202616883A (en)	2023-05-18	2026-03-25	Merck Sharp & Dohme Llc	Compounds and adjuvant formulations useful in pneumococcal vaccines
EP4713008A2 (en)	2023-05-19	2026-03-25	GlaxoSmithKline Biologicals S.A.	Methods for eliciting an immune response to respiratory syncycial virus and streptococcus pneumoniae infection
TW202527906A (zh)	2023-09-14	2025-07-16	美商輝瑞股份有限公司	包含經結合之肺炎鏈球菌莢膜醣抗原之佐劑化致免疫性組成物及其用途
WO2025133971A1 (en)	2023-12-23	2025-06-26	Pfizer Inc.	Improved methods for producing bacterial capsular saccharide glycoconjugates
WO2025186705A2 (en)	2024-03-06	2025-09-12	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
WO2025219904A1 (en)	2024-04-19	2025-10-23	Pfizer Inc.	Improved methods for producing glycoconjugates by reductive amination in aprotic solvent
WO2025219908A2 (en)	2024-04-19	2025-10-23	Pfizer Inc.	Media and fermentation methods for polysaccharide production in bacterial cell culture

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0002004B1 (en)	1977-11-07	1982-03-24	Ciba-Geigy Ag	Process for the manufacture of fluorinated cationic compounds and their use as surfactants
CA1115210A (en) *	1977-11-28	1981-12-29	Dennis J. Carlo	Pneumococcal vaccine
US4221906A (en) *	1979-03-19	1980-09-09	American Cyanamid Company	Stabilization of pneumococcal polysaccharides
US4242501A (en) *	1979-08-08	1980-12-30	American Cyanamid Company	Purification of pneumococcal capsular polysaccharides
FR2495939B1 (fr) *	1980-12-11	1985-10-11	Merieux Inst	Procede de purification de polyosides de streptococcus pneumoniae et vaccin a base de polyosides ainsi purifies
US4686102A (en) *	1984-04-12	1987-08-11	American Cyanamid Company	Multivalent pneumococcal vaccine and preparation thereof
JPS6170994A (ja) *	1984-09-14	1986-04-11	Daikin Ind Ltd	環状（１→２）−β−Ｄ−グルカンの製法
IT1187753B (it) *	1985-07-05	1987-12-23	Sclavo Spa	Coniugati glicoproteici ad attivita' immunogenica trivalente
CA2059692C (en) *	1991-01-28	2004-11-16	Peter J. Kniskern	Pneumoccoccal polysaccharide conjugate vaccine
US5714354A (en) *	1995-06-06	1998-02-03	American Home Products Corporation	Alcohol-free pneumococcal polysaccharide purification process
RU2087156C1 (ru) *	1995-06-22	1997-08-20	Леонид Николаевич Падюков	Вакцина против пневмококковой инфекции
CA2316975C (en) *	1997-12-23	2009-03-24	North American Vaccine, Inc.	Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines
US6146902A (en) *	1998-12-29	2000-11-14	Aventis Pasteur, Inc.	Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
GB0108079D0 (en) *	2001-03-30	2001-05-23	Microbial Technics Ltd	Protein
GB0115176D0 (en) *	2001-06-20	2001-08-15	Chiron Spa	Capular polysaccharide solubilisation and combination vaccines
EP2425853A1 (en)	2005-04-08	2012-03-07	Wyeth LLC	Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
US7709001B2 (en) *	2005-04-08	2010-05-04	Wyeth Llc	Multivalent pneumococcal polysaccharide-protein conjugate composition
DK3466982T3 (da) *	2005-04-08	2020-08-03	Wyeth Llc	Separation af forurenende kontaminanter fra streptococcus pneumoniae-polysaccharid ved ph-manipulation
DK2129693T3 (en) *	2007-03-23	2017-02-13	Wyeth Llc	BRIEF PURIFICATION PROCEDURE FOR THE PREPARATION OF STREPTOCOCCUS PNEUMONIAE-Capsule POLYACCHARIDES

2008
- 2008-03-20 DK DK08732592.4T patent/DK2129693T3/en active
- 2008-03-20 PT PT87325924T patent/PT2129693T/pt unknown
- 2008-03-20 JP JP2009554744A patent/JP5688902B2/ja active Active
- 2008-03-20 HU HUE11194173A patent/HUE039169T2/hu unknown
- 2008-03-20 ES ES18177128T patent/ES2922132T3/es active Active
- 2008-03-20 CL CL200800831A patent/CL2008000831A1/es unknown
- 2008-03-20 SI SI200831741A patent/SI2129693T1/sl unknown
- 2008-03-20 ES ES08732592.4T patent/ES2614249T3/es active Active
- 2008-03-20 SI SI200831984T patent/SI2436700T1/sl unknown
- 2008-03-20 KR KR1020097021976A patent/KR101500771B1/ko active Active
- 2008-03-20 HU HUE18177128A patent/HUE059085T2/hu unknown
- 2008-03-20 EP EP18177128.8A patent/EP3406635B1/en active Active
- 2008-03-20 DK DK11194173.8T patent/DK2436700T5/en active
- 2008-03-20 DK DK18177128.8T patent/DK3406635T3/da active
- 2008-03-20 CA CA2681570A patent/CA2681570C/en active Active
- 2008-03-20 AU AU2008231041A patent/AU2008231041B2/en active Active
- 2008-03-20 BR BRPI0809212A patent/BRPI0809212B8/pt active IP Right Grant
- 2008-03-20 WO PCT/US2008/057688 patent/WO2008118752A2/en not_active Ceased
- 2008-03-20 MY MYPI20093908 patent/MY150927A/en unknown
- 2008-03-20 ES ES11194173.8T patent/ES2677353T3/es active Active
- 2008-03-20 RU RU2009135485/10A patent/RU2516340C2/ru active
- 2008-03-20 PT PT181771288T patent/PT3406635T/pt unknown
- 2008-03-20 EP EP08732592.4A patent/EP2129693B1/en active Active
- 2008-03-20 EP EP11194173.8A patent/EP2436700B8/en active Active
- 2008-03-20 PL PL08732592T patent/PL2129693T3/pl unknown
- 2008-03-20 NZ NZ580134A patent/NZ580134A/en unknown
- 2008-03-20 US US12/052,525 patent/US8652480B2/en active Active
- 2008-03-20 PT PT111941738T patent/PT2436700T/pt unknown
- 2008-03-20 PL PL18177128.8T patent/PL3406635T3/pl unknown
- 2008-03-20 SI SI200832196T patent/SI3406635T1/sl unknown
- 2008-03-20 HU HUE08732592A patent/HUE031567T2/hu unknown
- 2008-03-20 KR KR1020157002150A patent/KR20150021127A/ko not_active Ceased
- 2008-03-20 PL PL11194173T patent/PL2436700T3/pl unknown
- 2008-03-20 UA UAA200909741A patent/UA99278C2/ru unknown
- 2008-03-20 MX MX2009010221A patent/MX2009010221A/es active IP Right Grant
- 2008-03-20 CN CN200880012946.2A patent/CN101663327B/zh active Active
2009
- 2009-09-17 HN HN2009001965A patent/HN2009001965A/es unknown
- 2009-09-21 NI NI200900172A patent/NI200900172A/es unknown
- 2009-09-21 GT GT200900249A patent/GT200900249A/es unknown
- 2009-09-22 ZA ZA200906625A patent/ZA200906625B/xx unknown
- 2009-09-22 IL IL201106A patent/IL201106A/en active IP Right Grant
- 2009-09-23 EC EC2009009652A patent/ECSP099652A/es unknown
- 2009-09-23 CR CR11041A patent/CR11041A/es unknown
- 2009-10-20 CO CO09117278A patent/CO6251324A2/es active IP Right Grant
2014
- 2014-01-24 US US14/163,863 patent/US8999697B2/en active Active
2015
- 2015-01-27 JP JP2015013167A patent/JP2015143225A/ja not_active Withdrawn
- 2015-02-27 US US14/633,141 patent/US9675681B2/en active Active
2017
- 2017-03-23 JP JP2017056848A patent/JP6825950B2/ja active Active
- 2017-08-08 CL CL2017002029A patent/CL2017002029A1/es unknown
2018
- 2018-11-06 JP JP2018208647A patent/JP2019048844A/ja not_active Withdrawn
2020
- 2020-01-31 JP JP2020014532A patent/JP6872649B2/ja active Active

Also Published As

Publication number	Publication date
PT2436700T (pt)	2018-07-17
SI2129693T1 (sl)	2017-01-31
MX2009010221A (es)	2009-10-19
PL2436700T3 (pl)	2018-12-31
BRPI0809212B8 (pt)	2021-05-25
NZ580134A (en)	2011-10-28
ES2677353T3 (es)	2018-08-01
EP2129693B1 (en)	2016-12-07
HUE039169T2 (hu)	2018-12-28
HN2009001965A (es)	2011-10-06
US8652480B2 (en)	2014-02-18
ECSP099652A (es)	2009-10-30
JP2017141263A (ja)	2017-08-17
KR101500771B1 (ko)	2015-03-18
AU2008231041B2 (en)	2013-03-07
KR20150021127A (ko)	2015-02-27
CN101663327B (zh)	2014-05-07
ES2677353T8 (es)	2018-09-25
EP2129693A2 (en)	2009-12-09
WO2008118752A2 (en)	2008-10-02
JP2010521972A (ja)	2010-07-01
AU2008231041A1 (en)	2008-10-02
PL3406635T3 (pl)	2022-08-22
ES2614249T3 (es)	2017-05-30
SI3406635T1 (sl)	2022-08-31
JP6872649B2 (ja)	2021-05-19
JP5688902B2 (ja)	2015-03-25
AU2008231041A8 (en)	2009-11-12
NI200900172A (es)	2010-09-07
US20140363463A1 (en)	2014-12-11
PL2129693T3 (pl)	2017-07-31
RU2009135485A (ru)	2011-04-27
PT2129693T (pt)	2017-02-14
US9675681B2 (en)	2017-06-13
JP2015143225A (ja)	2015-08-06
EP2436700A1 (en)	2012-04-04
ZA200906625B (en)	2010-07-28
JP2020169160A (ja)	2020-10-15
JP6825950B2 (ja)	2021-02-03
WO2008118752A3 (en)	2008-11-20
HK1141815A1 (en)	2010-11-19
DK2129693T3 (en)	2017-02-13
EP3406635A1 (en)	2018-11-28
CN101663327A (zh)	2010-03-03
BRPI0809212B1 (pt)	2019-06-18
ES2922132T3 (es)	2022-09-08
EP2436700B1 (en)	2018-06-20
JP2019048844A (ja)	2019-03-28
CL2017002029A1 (es)	2018-05-18
GT200900249A (es)	2010-07-28
IL201106A0 (en)	2010-05-17
RU2516340C2 (ru)	2014-05-20
US8999697B2 (en)	2015-04-07
CA2681570A1 (en)	2008-10-02
US20150165017A1 (en)	2015-06-18
DK3406635T3 (da)	2022-05-30
CA2681570C (en)	2016-05-03
CR11041A (es)	2009-12-30
CO6251324A2 (es)	2011-02-21
EP2436700B8 (en)	2018-08-01
CL2008000831A1 (es)	2008-07-04
KR20100015765A (ko)	2010-02-12
DK2436700T5 (en)	2018-09-03
MY150927A (en)	2014-03-14
US20080286838A1 (en)	2008-11-20
DK2436700T3 (en)	2018-08-13
EP3406635B1 (en)	2022-05-11
IL201106A (en)	2014-04-30
SI2436700T1 (sl)	2018-09-28
HUE059085T2 (hu)	2022-10-28
BRPI0809212A2 (pt)	2014-09-02
PT3406635T (pt)	2022-07-08
HUE031567T2 (hu)	2017-07-28

Publication	Publication Date	Title
MY150927A (en)	2014-03-14	Shortened purification process for the production of capsular streptococcus pneumoniae polysaccharides
IL233893A0 (en)	2014-09-30	Purification of polysaccharides of streptococcus pneumoniae type 3
NZ600189A (en)	2014-04-30	Novel 7beta-hydroxysteroid dehydrogenases and their use
MX351345B (es)	2017-10-11	Proceso de conjugación de polisacáridos bacterianos con proteínas portadoras.
MY182355A (en)	2021-01-20	Hmo synthesis
WO2011031020A3 (en)	2011-06-23	Method for preparing a fermented soybean meal using bacillus strains
MX2009009452A (es)	2009-09-14	Extracto bacteriano para trastornos respiratorios y proceso para su preparacion.
WO2014080423A3 (en)	2015-03-19	Production of high yields of bacterial polysaccharides
MX2009007632A (es)	2009-07-24	Precipitacion de polielectrolito y purificacion de proteinas.
EP2894225A1 (en)	2015-07-15	Production method for capsular polysaccharide having pneumococcal serotype
JO2682B1 (en)	2013-03-03	Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
WO2010101855A3 (en)	2010-12-16	Microbial derived isoprene and methods for making the same
MY202666A (en)	2024-05-14	Method for removal of impurities from bacterial capsular polysaccharide based preparations
MX2020000224A (es)	2020-08-17	Purificacion de polisacárido para la produccion de vacuna utilizando enzimas líticas, filtración de flujo tangencial y cromatografía multimodal.
PL2027280T3 (pl)	2010-12-31	Sposób wytwarzania polimyksyny B wykorzystujący (paeni) bacillus polymyxa
MY159790A (en)	2017-01-31	Highly bridged peptides from actinomadura namibiensis
UA95630C2 (ru)	2011-08-25	Лизобактинамиды, способ их получения (варианты) и применение их как антибактериального средства
CN103013948B (zh)	2015-04-15	一种纯化梭形赖氨酸芽孢杆菌产氨基甲酸乙酯酶的方法
CN102040667B (zh)	2012-08-22	海参多糖中蛋白的生物脱除方法
MX2025003177A (es)	2025-05-02	Metodo para la purificacion de polisacaridos capsulares
CN103665056A (zh)	2014-03-26	一种氨基葡萄糖硫酸盐的制备方法
BR112022015796A2 (pt)	2022-10-11	Purificação de sacarídeos
CN102453077B (zh)	2013-12-25	氟代诺斯菌素及其制法和用途
MX2007013228A (es)	2008-01-16	Metodo para producir cepas sobreproductoras de staphylococcus aureus.
IN2013MU03109A (ru)	2015-07-17